APA (7th ed.) Citation

Burnett, A., Russell, N., & Hills, R. (2016). Higher daunorubicin exposure benefits FLT3 mutated acute myeloid leukemia. American Society of Hematology.

Chicago Style (17th ed.) Citation

Burnett, A., N. Russell, and R. Hills. Higher Daunorubicin Exposure Benefits FLT3 Mutated Acute Myeloid Leukemia. American Society of Hematology, 2016.

MLA (9th ed.) Citation

Burnett, A., et al. Higher Daunorubicin Exposure Benefits FLT3 Mutated Acute Myeloid Leukemia. American Society of Hematology, 2016.